Details for Patent: 8,143,271
Which drugs does patent 8,143,271 protect, and when does it expire?
Patent 8,143,271 protects ZELBORAF and is included in one NDA.
This patent has eighty-three patent family members in thirty-four countries.
Summary for Patent: 8,143,271
| Title: | Compounds and methods for kinase modulation, and indications therefor |
| Abstract: | Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases. |
| Inventor(s): | Prabha N. Ibrahim, Dean R. Artis, Ryan Bremer, Chao Zhang, Jiazhong Zhang, James Tsai, Klaus-Peter Hirth, Gideon Bollag, Hanna Cho |
| Assignee: | Plexxikon Inc |
| Application Number: | US13/216,200 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 8,143,271
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hoffmann La Roche | ZELBORAF | vemurafenib | TABLET;ORAL | 202429-001 | Aug 17, 2011 | RX | Yes | Yes | 8,143,271 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,143,271
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1893612 | ⤷ Start Trial | C300534 | Netherlands | ⤷ Start Trial |
| European Patent Office | 1893612 | ⤷ Start Trial | PA2012010 | Lithuania | ⤷ Start Trial |
| European Patent Office | 1893612 | ⤷ Start Trial | 12C0040 | France | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
